To ensure that all New Mexicans have access to world-class cancer care and benefit from advances in cancer research, the UNM Comprehensive Cancer Center will provide outstanding cancer diagnosis and treatment, conduct world-class research to discover the causes and the cures for cancer, educate the next generation of cancer healthcare professionals, and overcome the significant cancer health disparities in the Southwest through community-based outreach programs.
Come visit any time! Our Retail Pharmacy Address is:
Cancer Center Pharmacy
1201 Camino De Salud NE Suite 1605
Albuquerque, NM 87102
PRACTICE DETAILS (how many providers, how many employees, etc):
The UNM Cancer Center is home to New Mexico’s largest and most experienced team of cancer experts. Our 130 board-certified oncology physicians represent every cancer specialty and are recruited from some of the world’s leading cancer institutions. In addition to providing comprehensive, compassionate cancer treatment, our physicians collaborate with the UNM Cancer Center’s internationally recognized team of researchers to translate cutting-edge discoveries into the most advanced cancer care available in New Mexico.
QUALIFICATIONS/CREDENTIALS (are you QOPI certified, etc.)
- NCI designated “Comprehensive Cancer Center”
- QOPI certified
- Commission on Cancer
INTRODUCTION TO PHARMACY SERVICES STAFF W/ BRIEF BIO:
Our integral pharmacy team works together to provide care and services in multiple settings, including inpatient, outpatient clinics, outpatient infusion, clinical research, outpatient retail pharmacy, and soon outpatient bone marrow transplant services. Our oral oncology team comprises of a dedicated 0.75 FTE pharmacist, Tiffany Menhorn, a clinical pharmacist, Harmony Bowles, and our outpatient retail pharmacist Amy Zarick Jones. Our team collaborates closely with our inpatient pharmacists and amazing pharmacy technicians and liaisons. We provide education and follow up to currently over 300 oral chemotherapy patients, of which we are actively following.
DISPENSING TYPE (RETAIL VS DISPENSARY)
SERVICES PROVIDED (BONE MARROW, RADIATION, CHEMO)
Radiology, Pathology, Chemotherapy, Radiation Therapy, Cancer Surgery, Cancer Genetic Assessment, Bone Marrow Transplant, Clinical Research (NCI-Designated Comprehensive Cancer Center)
WHY DID YOU JOIN NCODA?
Desire to better our knowledge and learn best practices, specifically in regards to oral chemotherapy. To become part of a well-recognized organization and sharing its mission to provide positive outcomes for patients
HOW DID YOU BECOME A MEMBER?
Online via NCODA website.
HOW DID YOU HEAR ABOUT US?
NCODA was discovered while talking with other pharmacists involved with oral chemotherapy education at other institutions and while searching for resources and organizations with more of a focus on oral chemotherapy.
HOW CAN NCODA HELP YOU?
After going to our first NCODA meeting, the 2019 Fall Summit, we were so impressed to learn about all the resources NCODA offers, particularly the Oral Chemotherapy Education sheets. the Positive Quality Interventions, and Treatment Support Kits. We hope to continue to utilize and start implementing many of these up-to-date resources to better our practices and ultimately provide better patient care. We look forward to future meetings and learning about new resources and standards, as well as, the opportunity to continue to network with other institutions.
HOW WOULD YOU LIKE TO BE MORE INVOLVED WITH NCODA?
When our institution is better able to implement NCODA resources, we would like to be able to share our experiences with NCODA. We hope by doing this, we will be able to help other practices and contribute to the improvement of patient care.
WHAT ARE SOME CHALLENGES YOU FACE NOW OR WILL FACE IN THE FUTURE OF ONCOLOGY?
Limited resources still proves to be one of our greatest challenges in order to provide better oral chemotherapy follow up, especially as the number or patients prescribed oral chemotherapy continues to rise. We realize the importance of follow up and how we can have an impact early on with adherence and managing toxicities. We would ideally like to follow up with patients sooner and more frequently. Communication continues to be another challenge with sometimes unclear starts of therapy and lack of communication of dose changes or discontinuation of therapy. Delay In therapy, determining delivery of medication, late education, and drug waste are other issues, particularly when oral chemotherapy is filled at outside pharmacies.